HIV Treatment Reduces Accelerated Biological Aging by Nearly Four Years

Advances in antiretroviral therapy (ART) have transformed HIV from a life‑threatening infection into a manageable chronic condition—but questions remain about how effectively treatment mitigates long‑term biological damage. 

Growing evidence suggests that people with HIV experience accelerated biological aging, driven by chronic inflammation and immune dysregulation, contributing to elevated risks of cardiovascular and other age‑related diseases. 

At ESCMID Global 2026, researchers presented new data showing that ART can partially reverse this accelerated aging at the molecular level, reducing biological age by nearly four years.

Technology Networks | Published: April 28, 2026